MedTrace Logo

Treating the Fear of Gaining Weight in Anorexia Nervosa

NCT04028635 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2020-11-17

No results posted yet for this study

Summary

The main aim of this study is to develop a virtual reality (VR) embodiment-based exposure technique to improve the treatment of anorexia nervosa (AN). A systematic and hierarchical body exposure intervention in which the patient owns a virtual avatar is proposed. At first, the virtual body matches with the real measurements of the patient, then the experimenter will progressively increase Body Mass Index (BMI) values of the virtual body during the exposure sessions until a healthy BMI value is reached (e.g. BMI score of 20). In this study a VR embodiment-based technique that combines visuo-motor and a visuo-tactile stimulation procedures is proposed in order to increase illusory feelings of ownership over the virtual body. It is hypothesised that adding a VR-based body exposure intervention to the classical cognitive behavioral therapy (CBT) will significantly reduce symptomatology in AN patients.

Conditions

  • Anorexia Nervosa

Interventions

BEHAVIORAL

Cognitive-behavioral therapy plus VR-based body exposure

Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions.

BEHAVIORAL

Cognitive behavioral therapy

Usual CBT

Sponsors & Collaborators

  • Hospital Sant Joan de Deu

    collaborator OTHER

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Hospital San Carlos, Madrid

    collaborator OTHER

  • Hospital Universitari de Bellvitge

    collaborator OTHER

  • Istituto Auxologico Italiano

    collaborator OTHER

  • University of Barcelona

    lead OTHER

Principal Investigators

  • José Gutiérrez-Maldonado, Prof. Dr. · University of Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2020-04-30
Completion
2020-07-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04028635 on ClinicalTrials.gov